Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity.

Immunometabolism has been demonstrated to control immune tolerance and the pathogenic events leading to autoimmunity. Compelling experimental evidence also suggests that intracellular metabolic programs influence differentiation, phenotype, proliferation, and effector functions of anti-inflammatory CD4+CD25+Foxp3+ regulatory T (Treg) cells. Indeed, alterations in intracellular metabolism associate with quantitative and qualitative impairments of Treg cells in several pathological conditions. In this review, we summarize the most recent advances linking how metabolic pathways control Treg cell homeostasis and their alterations occurring in autoimmunity. Also, we analyze how metabolic manipulations could be employed to restore Treg cell frequency and function with the aim to create novel therapeutic opportunities to halt immune-mediated disorders.

[1]  Xuefeng Wang,et al.  Oleic acid availability impacts thymocyte preprogramming and subsequent peripheral T_reg cell differentiation , 2023, Nature immunology.

[2]  T. Atsumi,et al.  Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming , 2023, Nature Communications.

[3]  G. Tsokos,et al.  Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity , 2022, Science advances.

[4]  C. Procaccini,et al.  Regulatory T cells as metabolic sensors. , 2022, Immunity.

[5]  D. Cui,et al.  mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus. , 2022, Clinical immunology.

[6]  H. Sytwu,et al.  Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes , 2022, International journal of molecular sciences.

[7]  L. Morel,et al.  Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism , 2021, JCI insight.

[8]  D. Greco,et al.  Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential. , 2021, Immunity.

[9]  K. Tenbrock,et al.  Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat? , 2021, Frontiers in Immunology.

[10]  Nicole M. Chapman,et al.  Lipid signalling enforces Treg cell functional specialization in tumours , 2021, Nature.

[11]  N. Yosef,et al.  Oleic acid restores suppressive defects in tissue-resident FOXP3 regulatory T cells from patients with multiple sclerosis. , 2020, The Journal of clinical investigation.

[12]  N. Sachdeva,et al.  Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes , 2020, Scientific Reports.

[13]  G. Garinis,et al.  Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity. , 2020, Cell metabolism.

[14]  E. Pålsson-McDermott,et al.  Targeting immunometabolism as an anti-inflammatory strategy , 2020, Cell Research.

[15]  M. Scholz,et al.  Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism , 2020, Cell.

[16]  G. Tsokos,et al.  T cell Metabolism in Lupus , 2020, Immunometabolism.

[17]  J. Wolchok,et al.  CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors , 2019, Nature Immunology.

[18]  E. Pearce,et al.  Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function , 2019, Cell metabolism.

[19]  S. Weinberg,et al.  Requirement of Mitochondrial Transcription Factor A in Tissue-Resident Regulatory T Cell Maintenance and Function , 2019, Cell reports.

[20]  Xuefeng Yu,et al.  Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production. , 2019, American journal of translational research.

[21]  M. López-Hoyos,et al.  Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome , 2019, Front. Immunol..

[22]  Y. Huang,et al.  Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis , 2019, Lupus.

[23]  Dragica Gajić,et al.  Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice , 2019, Front. Immunol..

[24]  M. Mehta,et al.  Mitochondrial complex III is essential for regulatory T cell suppressive function , 2018, Nature.

[25]  Qianqian Wan,et al.  Altered frequency of Th17 and Treg cells in new‐onset systemic lupus erythematosus patients , 2018, European journal of clinical investigation.

[26]  E. Coccia,et al.  Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth , 2018, Proceedings of the National Academy of Sciences.

[27]  S. Faraone,et al.  Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial , 2018, The Lancet.

[28]  A. Cava.  Tregs in SLE: an Update. , 2018 .

[29]  D. M. Smith,et al.  Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis , 2017, Immunity.

[30]  V. De Rosa,et al.  Metabolic pressure and the breach of immunological self-tolerance , 2017, Nature Immunology.

[31]  D. Hardie,et al.  The mechanisms of action of metformin , 2017, Diabetologia.

[32]  Qianming Chen,et al.  D-mannose induces regulatory T cells and suppresses immunopathology , 2017, Nature Medicine.

[33]  Vaishali R. Moulton,et al.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. , 2017, Trends in molecular medicine.

[34]  J. Correale,et al.  Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis , 2017, The Journal of Immunology.

[35]  M. Warmoes,et al.  Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression , 2016, Nature Immunology.

[36]  D. Hafler,et al.  AKT isoforms modulate Th1‐like Treg generation and function in human autoimmune disease , 2016, EMBO reports.

[37]  Sirong He,et al.  Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice. , 2016, Molecular immunology.

[38]  Guixiu Shi,et al.  Rapamycin reverses the senescent phenotype and improves immuno-regulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway , 2016, Aging.

[39]  Li Guo,et al.  Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice , 2016, Journal of Neuroimmunology.

[40]  D. Munn,et al.  IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. , 2016, Trends in immunology.

[41]  R. Gold,et al.  Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. , 2015, Immunity.

[42]  V. De Rosa,et al.  Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants , 2015, Nature Immunology.

[43]  M. Cho,et al.  Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance , 2015, PloS one.

[44]  M. Buck,et al.  T cell metabolism drives immunity , 2015, The Journal of experimental medicine.

[45]  R. Talaat,et al.  Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. , 2015, Cytokine.

[46]  M. Thurnher,et al.  T lymphocyte regulation by mevalonate metabolism , 2015, Science Signaling.

[47]  D. Wallace,et al.  Essential role of mitochondrial energy metabolism in Foxp3+ T‐regulatory cell function and allograft survival , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  B. Croker,et al.  Normalization of CD4+ T cell metabolism reverses lupus , 2015, Science Translational Medicine.

[49]  Nataliya Gorinski,et al.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells , 2014, Nature Medicine.

[50]  F. Carbone,et al.  Regulatory T cell proliferative potential is impaired in human autoimmune disease , 2013, Nature Medicine.

[51]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[52]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[53]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[54]  Stephen V Faraone,et al.  N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. , 2012, Arthritis and rheumatism.

[55]  J. Bluestone,et al.  Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function , 2012, Diabetes.

[56]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[57]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[58]  T. Horvath,et al.  An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. , 2010, Immunity.

[59]  F. Fallarino,et al.  IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis , 2010, The Journal of Immunology.

[60]  G. Martino,et al.  Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation , 2010, Journal of Neuroimmunology.

[61]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[62]  T. Whiteside,et al.  Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin , 2009, PloS one.

[63]  Hiraku Ono,et al.  Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. , 2008, Cell metabolism.

[64]  M. Salmon,et al.  The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. , 2008, The Journal of clinical investigation.

[65]  E. Bonifacio,et al.  Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells , 2008, Diabetes.

[66]  S. Woods,et al.  Regulation of food intake through hypothalamic signaling networks involving mTOR. , 2008, Annual review of nutrition.

[67]  M. Battaglia,et al.  Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.

[68]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[69]  V. De Rosa,et al.  Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[70]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.